Dolby Laboratories, Inc.
DLB
$75.75
-$0.04-0.05%
NYSE
| 12/27/2024 | 09/27/2024 | 06/28/2024 | 03/29/2024 | 12/29/2023 | |
|---|---|---|---|---|---|
| Revenue | 2.71% | -2.00% | -2.17% | -0.75% | 3.50% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.71% | -2.00% | -2.17% | -0.75% | 3.50% |
| Cost of Revenue | -0.64% | -7.91% | -7.87% | -0.49% | 4.94% |
| Gross Profit | 3.16% | -1.22% | -1.39% | -0.78% | 3.31% |
| SG&A Expenses | 1.68% | -1.30% | 0.43% | 3.83% | -0.28% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.14% | -2.69% | -0.71% | 3.34% | 2.23% |
| Operating Income | 15.01% | 0.72% | -7.72% | -15.23% | 9.37% |
| Income Before Tax | 37.59% | 24.97% | -3.76% | -20.92% | 3.17% |
| Income Tax Expenses | 28.61% | -0.51% | -11.58% | -21.27% | 1.59% |
| Earnings from Continuing Operations | 39.53% | 31.08% | -1.88% | -20.85% | 3.51% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -41.19% | -152.13% | -984.39% | -520.29% | -1,452.68% |
| Net Income | 39.52% | 30.48% | -3.09% | -21.46% | 2.62% |
| EBIT | 15.01% | 0.72% | -7.72% | -15.23% | 9.37% |
| EBITDA | 10.85% | -1.48% | -7.42% | -13.12% | 5.84% |
| EPS Basic | 39.57% | 30.88% | -2.69% | -20.56% | 5.21% |
| Normalized Basic EPS | 13.37% | 6.86% | 1.42% | -5.23% | 23.08% |
| EPS Diluted | 40.34% | 31.01% | -2.74% | -20.68% | 4.22% |
| Normalized Diluted EPS | 13.95% | 6.91% | 1.27% | -5.55% | 22.36% |
| Average Basic Shares Outstanding | -0.04% | -0.24% | -0.51% | -1.69% | -3.04% |
| Average Diluted Shares Outstanding | -0.59% | -0.42% | -0.34% | -1.23% | -2.46% |
| Dividend Per Share | 10.53% | 10.81% | 11.11% | 10.38% | 9.62% |
| Payout Ratio | -0.21% | -0.15% | 0.13% | 0.37% | 0.03% |